Public Health Monitoring in the Hauts-de-France Region. Update as of September 30, 2022.

Key Points

COVID-19

  • Epidemic activity continues to rise regionally and across all five departments.

  • Increased viral circulation in the middle age groups (15–44 years and 45–64 years) and stabilization among those under 15 years of age. High activity among the most vulnerable (>65 years) with a more pronounced increase in the incidence rate in the North (+64%).

  • Continued increase in consultations for suspected COVID-19 (SOS Médecins and SAU) and acute respiratory infections (Sentinel Network) in week 38.

  • In hospitals, a slight increase in new admissions to critical care.

  • Slight increase in vaccination coverage among the most vulnerable (over 60 years old) eligible for the second booster.

Monkeypox

  • 194 confirmed cases recorded in Hauts-de-France, representing 5% of cases residing in France. The number of new confirmed cases has continued to decline in recent weeks.

  • 2.1% of cases were hospitalized following infection with the Monkeypox virus, and no deaths have been reported in the region.

Bronchiolitis

  • Non-epidemic phase, but activity is increasing at SOS Médecins and in the region’s emergency departments.

Asthma

  • Stabilization in the use of asthma care in community settings and hospitals (emergency departments and hospitalizations).

In relation to

Our latest news

news

Etienne Pot Appointed Interim Director General of Santé publique France

news

Arboviral Diseases in 2026: Mosquito-Borne Diseases Continue to Spread This...

news

Andes Hantavirus: Implementation of epidemiological investigations and...